These findings seem to indicate that MRGPRX2 on bone marrow MCs is unlikely to play a major role in WVA, nor does its expression advance prediction of the occurrence of wasp venom anaphylaxis within the CMCD population. The gene discussed is MRGPRX2; the disease is cutaneous mastocytosis.